Page 23 - Accel News Today

Xalts is expected to launch multiple fund products linked to digital assets, including mutual funds and ETFs listed on several global exchanges. It is also leveraging its technology platform to partner with several asset management firms and staking infrastructure providers to jointly launch and manage mutual funds and ETFs.

Bengaluru (Karnataka) [India], September 22 (ANI/PRNewswire): Binocs, the crypto taxation and Web3 portfolio tracking platform, today announced raising USD 4 million in its seed round from global institutional investors led by BEENEXT, along with Arkam Ventures, Accel, Saison Capital, Premji Invest, Blume Ventures, and Better Capital. The company is also backed by several stellar crypto-native angel investors from the US and India. Binocs, which is launching its platform in the US, UK, South Afr...

Managed detection and response (MDR) start-up Huntress has secured a $40 million debt financing round to speed up global expansion plans.

"There is now a flight to fundamentals," Olu Oyinsan, of Oui Capital, said.

The local arm of the 39-year-old global Venture Capital major engages deeply with early-stage start-ups and stays invest-ed with them from idea to IPO - Issue Date: Sep 04, 2022

The firm was initially targeting to raise Rs 1000 crore for the second fund. A first close of Rs 500 crore was announced in August 2021.

Jify.co, in a release, said that it will use the funding "to strengthen its fintech product offering, ramp up customer acquisition across sectors and cities, while also driving adoption among the workforce."

ACCEL’s Ajyal Center recently became the first organization outside of the United States to be recognized with an NCASES accreditation for special education.

Cryo-Cell International (OTCMKTS:CCEL – Get Rating) and Marpai (NASDAQ:MRAI – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings. Insider and Institutional Ownership 10.7% of Cryo-Cell International shares are […]

Devo Technology has closed a new $100 million funding round that pushes its valuation in the $2 billion range.